Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested Capital

AIM ImmunoTech (AIM) Return on Sales (2018 - 2024)

Historic Return on Sales for ImmunoTech (AIM) over the last 9 years, with Q3 2024 value amounting to 215.45%.

  • ImmunoTech's Return on Sales fell 381200.0% to 215.45% in Q3 2024 from the same period last year, while for Sep 2024 it was 215.45%, marking a year-over-year decrease of 752800.0%. This contributed to the annual value of 119.75% for FY2024, which is 382500.0% up from last year.
  • ImmunoTech's Return on Sales amounted to 215.45% in Q3 2024, which was down 381200.0% from 199.65% recorded in Q2 2024.
  • ImmunoTech's 5-year Return on Sales high stood at 81.04% for Q1 2020, and its period low was 215.45% during Q4 2023.
  • Moreover, its 3-year median value for Return on Sales was 135.01% (2023), whereas its average is 144.95%.
  • Within the past 5 years, the most significant YoY rise in ImmunoTech's Return on Sales was -381200bps (2024), while the steepest drop was -1122700bps (2024).
  • Quarter analysis of 3 years shows ImmunoTech's Return on Sales stood at 92.69% in 2020, then tumbled by -132bps to 215.45% in 2023, then changed by 0bps to 215.45% in 2024.
  • Its last three reported values are 215.45% in Q3 2024, 199.65% for Q2 2024, and 199.65% during Q1 2024.